Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 72
- −1 vs. Q1 2026
- Portfolio value
- $213.8M
- +$38.2M (+21.7%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GOSSGossamer Bio, Inc. | COM | 18,176 | $2.99K | <0.1% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 39,062 | $20.2K | <0.1% | −511−1.3% | Reduced | History |
| LPCNLipocine Inc. | COM NEW | 16,712 | $42.8K | <0.1% | −95,074−85.1% | Reduced | History |
| QNRXQuoin Pharmaceuticals Ltd. | ADR | 20,000 | $96.8K | <0.1% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 165,094 | $161.7K | 0.1% | 00.0% | Unchanged | History |
| KYNBKyntra Bio, Inc. | COM NEW | 22,566 | $170.4K | 0.1% | 00.0% | Unchanged | History |
| OCULOcular Therapeutix, Inc | COM | 20,655 | $202.8K | 0.1% | −299,345−93.5% | Reduced | History |
| LUNGPulmonx Corp | COM | 200,543 | $260.7K | 0.1% | −49,678−19.9% | Reduced | History |
| VYGRVoyager Therapeutics, Inc. | COM | 75,147 | $263.0K | 0.1% | +229+0.3% | Added | History |
| KBDCKayne Anderson BDC, Inc. | COM SHS | 20,000 | $270.6K | 0.1% | 00.0% | Unchanged | History |
| GRCEGrace Therapeutics, Inc. | CL A | 120,000 | $272.4K | 0.1% | +70,000+140.0% | Added | History |
| IVVDInvivyd, Inc. | COM | 342,275 | $298.6K | 0.1% | +342,275 | New | History |
| CSTLCastle Biosciences Inc | COM | 12,984 | $309.7K | 0.1% | +84+0.7% | Added | History |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 14,352 | $345.6K | 0.2% | +14,352 | New | History |
| TRINTrinity Capital Inc. | COM | 20,000 | $357.8K | 0.2% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 20,000 | $364.2K | 0.2% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 42,952 | $419.6K | 0.2% | −41,000−48.8% | Reduced | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 30,000 | $424.5K | 0.2% | −345,000−92.0% | Reduced | History |
| ALTAltimmune, Inc. | COM NEW | 152,681 | $464.1K | 0.2% | +152,681 | New | History |
| CADLCandel Therapeutics, Inc. | COM | 47,756 | $491.9K | 0.2% | −12,244−20.4% | Reduced | History |
| SVRASavara Inc | COM | 80,000 | $492.8K | 0.2% | +80,000 | New | History |
| CAMPCamp4 Therapeutics Corp | COM | 120,000 | $524.4K | 0.2% | +120,000 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 55,000 | $596.8K | 0.3% | −140,000−71.8% | Reduced | History |
| URGNUroGen Pharma Ltd. | COM | 16,487 | $606.7K | 0.3% | +16,487 | New | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 48,505 | $645.1K | 0.3% | +48,505 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 8,741 | $651.0K | 0.3% | +53+0.6% | Added | History |
| SLNSilence Therapeutics plc | ADS | 71,218 | $782.0K | 0.4% | +71,218 | New | History |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 20,000 | $940.8K | 0.4% | +20,000 | New | History |
| ADAGAdagene Inc. | ADS | 240,000 | $1.01M | 0.5% | +240,000 | New | History |
| HROWHarrow, Inc. | COM | 24,000 | $1.02M | 0.5% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 29,847 | $1.03M | 0.5% | 00.0% | Unchanged | History |
| IMNMImmunome Inc. | COM | 50,000 | $1.06M | 0.5% | 00.0% | Unchanged | History |
| FCXFreeport-McMoran Inc | Stock | 18,035 | $1.13M | 0.5% | −50.0% | Reduced | History |
| NVONovo Nordisk A S | ADR | 24,000 | $1.15M | 0.5% | +24,000 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 21,032 | $1.27M | 0.6% | +32+0.2% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 24,000 | $1.29M | 0.6% | −76,000−76.0% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 313,616 | $1.33M | 0.6% | −149,983−32.4% | Reduced | History |
| FHTXFoghorn Therapeutics Inc. | COM | 281,937 | $1.38M | 0.6% | +207+0.1% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 6,000 | $1.47M | 0.7% | 00.0% | Unchanged | History |
| QDELQuidelOrtho Corp | COM | 89,377 | $1.57M | 0.7% | +6,829+8.3% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 29,000 | $1.65M | 0.8% | −200−0.7% | Reduced | History |
| BIOABioAge Labs, Inc. | COM | 69,000 | $1.69M | 0.8% | +69,000 | New | History |
| EQTEQT Corp | Stock | 34,619 | $1.84M | 0.9% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 9,000 | $1.94M | 0.9% | +4,000+80.0% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 220,000 | $2.24M | 1.0% | +220,000 | New | History |
| ABVXAbivax S.A. | SPONSORED ADS | 17,000 | $2.27M | 1.1% | +17,000 | New | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,350,000 | $2.27M | 1.1% | −150,000−10.0% | Reduced | History |
| QUREuniQure N.V. | SHS | 50,697 | $2.34M | 1.1% | −50,000−49.7% | Reduced | History |
| ZBIOZenas BioPharma, Inc. | COM | 93,601 | $2.38M | 1.1% | +23,601+33.7% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 4,506 | $2.44M | 1.1% | +6+0.1% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 57,758 | $2.48M | 1.2% | +13,758+31.3% | Added | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 199,000 | $2.49M | 1.2% | −20,000−9.1% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 30,000 | $2.56M | 1.2% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 69,900 | $2.60M | 1.2% | −195−0.3% | Reduced | History |
| HALOHalozyme Therapeutics, Inc. | COM | 33,251 | $2.60M | 1.2% | +23,151+229.2% | Added | History |
| ALKSAlkermes plc. | SHS | 50,000 | $2.62M | 1.2% | 00.0% | Unchanged | History |
| RLMDRelmada Therapeutics, Inc. | COM | 408,100 | $2.82M | 1.3% | −1,287−0.3% | Reduced | History |
| CMPXCompass Therapeutics, Inc. | COM | 1,675,000 | $3.67M | 1.7% | +209,133+14.3% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 35,018 | $4.29M | 2.0% | +18+0.1% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 171,000 | $4.33M | 2.0% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 449,019 | $4.40M | 2.1% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 27,190 | $4.58M | 2.1% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 57,200 | $4.97M | 2.3% | +10,000+21.2% | Added | History |
| NKTRNektar Therapeutics | COM NEW | 81,000 | $5.65M | 2.6% | +50,000+161.3% | Added | History |
| OVVOvintiv Inc. | COM | 107,500 | $5.66M | 2.6% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 178,110 | $5.83M | 2.7% | −31,890−15.2% | Reduced | History |
| BDSXBiodesix Inc | COM | 286,804 | $6.47M | 3.0% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM NEW | 666,196 | $6.66M | 3.1% | +40,216+6.4% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 385,900 | $6.78M | 3.2% | −59,500−13.4% | Reduced | History |
| LRCXLam Research Corp | Stock | 35,000 | $15.2M | 7.1% | −1,000−2.8% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 297,243 | $17.1M | 8.0% | −9,025−2.9% | Reduced | History |
| KLACKLA Corp | COM NEW | 178,471 | $53.8M | 25.2% | −20,359−10.2% | ReducedConverted for a 10-for-1 split | History |
Sold out since Q1 2026 (15)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| NVCRNovoCure Ltd | ORD SHS | 202,330 | $2.21M | 1.3% | History |
| ENGNenGene Therapeutics Inc. | COM | 250,000 | $1.70M | 1.0% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 62,000 | $1.30M | 0.7% | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 57,000 | $1.15M | 0.7% | History |
| VSTMVerastem, Inc. | COM NEW | 150,000 | $795.0K | 0.5% | History |
| APGEApogee Therapeutics, Inc. | COM | 9,000 | $757.5K | 0.4% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 14,000 | $563.2K | 0.3% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 16,860 | $561.8K | 0.3% | History |
| RCUSArcus Biosciences, Inc. | COM | 25,889 | $559.2K | 0.3% | History |
| RGNXREGENXBIO Inc. | COM | 66,270 | $555.3K | 0.3% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 127,025 | $454.8K | 0.3% | History |
| VRDNViridian Therapeutics, Inc. | COM | 20,100 | $393.2K | 0.2% | History |
| OMOutset Medical, Inc. | COM | 98,882 | $379.7K | 0.2% | History |
| PHRPhreesia, Inc. | COM | 14,300 | $119.8K | 0.1% | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 17,503 | $41.0K | <0.1% | History |